clinical trial · NCT07502417
A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participants
Healthy VolunteerEthinyl Estradiol + LevonorgestrelABBV-722
brief summary
The objective of this study is to assess the effect of repeated doses of ABBV-722 on the single dose pharmacokinetics (PK) of ethinyl estradiol and levonorgestrel.
started
Mar 27, 2026
primary completion
Jul 1, 2026
completion
Jul 1, 2026
last updated
Apr 28, 2026
official title
A Phase 1 Study to Assess the Effect of Multiple Doses of ABBV-722 on the Pharmacokinetics of a Combined Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol